1,091 results on '"Issa, Jean-Pierre J."'
Search Results
302. Abstract 5004: CpG island methylator phenotype in bladder cancer
303. Abstract 4572: Frequent MLL3 frameshift mutations in microsatellite-deficient colorectal cancer
304. DNA Methylation Does Not Stably Lock Gene Expression but Instead Serves as a Molecular Mark for Gene Silencing Memory
305. Effects ofTET2mutations on DNA methylation in chronic myelomonocytic leukemia
306. Epigenetic Silencing and Resistance to Imatinib Mesylate in CML
307. Dnmt3a is essential for hematopoietic stem cell differentiation
308. DNA Methylation Profiles of Primary Colorectal Carcinoma and Matched Liver Metastasis
309. Sequential Therapy with Allogeneic Transplant Followed by Low-Dose Azacitidine for CML Patients That Failed Multiple Tyrosine Kinase Inhibitors
310. Mechanisms of Resistance to Decitabine in the Myelodysplastic Syndrome
311. Frequent Alteration of MLL3 Frameshift Mutations in Microsatellite Deficient Colorectal Cancer
312. Aberrant DNA Methylation Is Associated with Disease Progression, Resistance to Imatinib and Shortened Survival in Chronic Myelogenous Leukemia
313. Detection of Bladder Cancer Using Novel DNA Methylation Biomarkers in Urine Sediments
314. Progesterone Receptor Isoform-Specific Promoter Methylation: Association of PRA Promoter Methylation with Worse Outcome in Breast Cancer Patients
315. Abstract 3004: Low levels of methylation in normal DNA mark a large subset of genes primed for hypermethylation in cancer
316. Tumor-associated methylation of the putative tumor suppressor AJAP1 gene and association between decreased AJAP1 expression and shorter survival in patients with glioma
317. Abstract 63: Methylation status of histone H3 Lysine 4 in normal melanocytes is a major determinant of DNA hypermethylation in melanoma
318. Time to Think Outside the (Genetic) Box
319. Dissecting DNA hypermethylation in cancer
320. Association between Folate Levels and CpG Island Hypermethylation in Normal Colorectal Mucosa
321. DNA methylation predicts recurrence from resected stage III proximal colon cancer
322. Chromatin Remodeling Is Required for Gene Reactivation after Decitabine-Mediated DNA Hypomethylation
323. DNA methylation profiling in cancer
324. Abstract 4908: Detection of bladder tumor by quantitative methylation specific real time PCR from urine sediment DNA
325. Abstract 4802: High-resolution analysis of chromatin association to nuclear lamina in normal and cancer cells
326. DNA Methylation Predicts Survival and Response to Therapy in Patients With Myelodysplastic Syndromes
327. Widespread and tissue specific age-related DNA methylation changes in mice
328. Epigenetic Profiles Distinguish Malignant Pleural Mesothelioma from Lung Adenocarcinoma
329. Validation of a DNA Methylation Signature of Favorable Prognosis in Newly Diagnosed Acute Myeloid Leukemia.
330. Digital Restriction Enzyme Analysis of Methylation (DREAM) by Next Generation Sequencing Yields High Resolution Maps of DNA Methylation.
331. Vorinostat in Combination with Decitabine for the Treatment of Relapsed or Newly Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS): A Phase I, Dose-Escalation Study.
332. DNA Methylation and Gene Expression Analysis in a Phase II Randomized Study of Decitabine Vs. Decitabine Plus Valproic Acid in MDS and AML.
333. Concordant DNA Methylation in Synchronous Colorectal Carcinomas
334. IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype
335. Targeting DNA Methylation
336. CpG island methylation profiling in human melanoma cell lines
337. Global DNA Hypomethylation (LINE-1) in the Normal Colon and Lifestyle Characteristics and Dietary and Genetic Factors
338. Tackling the methylome: recent methodological advances in genome-wide methylation profiling
339. Aging and DNA Methylation
340. Outcome of Patients (pts) with Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML) Post Decitabine Failure.
341. Hypermethylation of HOX Genes Is Associated with Longer Survival in Acute Myeloid Leukemia
342. An Sp1/Sp3 Binding Polymorphism Confers Methylation Protection
343. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation
344. Identification of Novel Tumor Markers in Prostate, Colon and Breast Cancer by Unbiased Methylation Profiling
345. Epigenetic-Genetic Interactions in theAPC/WNT, RAS/RAF, andP53Pathways in Colorectal Carcinoma
346. Downregulation of Histone H3 Lysine 9 Methyltransferase G9a Induces Centrosome Disruption and Chromosome Instability in Cancer Cells
347. Methylated CpG Island Amplification and Microarray (MCAM) for High-Throughput Analysis of DNA Methylation
348. Drug Sensitivity Prediction by CpG Island Methylation Profile in the NCI-60 Cancer Cell Line Panel
349. Classifying Leukemias Based on Epigenetic Alterations.
350. Genome-Wide Profiling of DNA Methylation Reveals a Class of Normally Methylated CpG Island Promoters
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.